One Product. Broad Pathogen Readiness.
One disinfectant platform for everyday environmental cleaning, broad pathogen coverage, high-consequence organisms, and outbreak readiness.
EraDOCate gives healthcare, food service, hospitality, schools, senior living, veterinary care, and high-turnover facilities one product with broad EPA-labeled activity against bacteria, viruses, fungi, C. difficile, C. auris, and Poliovirus Type 1. Instead of building a shelf of different disinfectants for different threats, facilities can standardize around one platform with clear contact times, controlled dilution, one training framework, and verification.
One product. Broad coverage. Proof behind the claim.
EraDOCate gives facilities one disinfectant platform for routine environmental cleaning, high-priority pathogens, and outbreak readiness.
One Product. Coverage Buyers Can Verify.
EraDOCate pairs broad pathogen coverage with clear EPA documentation so Infection Prevention, EVS, Food Safety, Operations, and Procurement can evaluate one product platform without guessing what the label supports.
Label-listed examples include MRSA, Pseudomonas aeruginosa, Acinetobacter baumanii, Listeria monocytogenes, E. coli O157:H7, Salmonella enterica, Influenza A, RSV, Human Coronavirus 229E, Rhinovirus Type 37, and the Norovirus surrogate.
The current primary EPA label includes C. difficile, C. auris, and Poliovirus Type 1 with a 4-minute wet contact time.
Primary EPA Reg. No. 54289-4 is qualified for Tier 1 enveloped, Tier 2 large non-enveloped, and Tier 3 small non-enveloped emerging viral pathogens under EPA's List Q framework.
Buyers can move directly from this page to the current EPA label, EPA pathogen lists, FDA outbreak information, and EraDOCate regulatory documents.
Broad Viral Readiness From One Product
EraDOCate brings direct label-listed viral claims and EPA Emerging Viral Pathogen qualification into one platform, giving facilities a broad viral-readiness story they can verify.
Label-listed examples include Influenza A H3N2, Avian Influenza A H9N2, RSV, Human Coronavirus 229E, HIV-1, Herpes simplex virus Types 1 and 2, Vaccinia virus, and Hepatitis B and C surrogates.
Label-listed examples include Human Rotavirus, Rhinovirus Type 37, Norovirus surrogate claim, and Poliovirus Type 1.
Primary EPA Reg. No. 54289-4 appears on EPA List Q for Tier 1, Tier 2, and Tier 3 emerging viral pathogens.
Primary EPA Reg. No. 54289-4 is qualified across EPA's Tier 1, Tier 2, and Tier 3 Emerging Viral Pathogen framework. Buyers can review the current EPA List Q details directly.
Current Outbreaks and Recent Lessons
Current CDC and FDA activity, along with recently closed investigations, shows where broad, fast, documented pathogen coverage matters across healthcare, food service, hospitality, schools, senior living, and veterinary environments.
Salmonella
Current outbreak: FDA and CDC are investigating a multistate Salmonella Javiana outbreak linked to jalapeño peppers from Sinaloa, Mexico. FDA's August 21 update lists 431 illnesses across 32 states, 57 hospitalizations, and no deaths. FDA is also tracking active Salmonella I 4,[5],12:i:-, Salmonella Oranienburg, and Salmonella Enteritidis investigations.
Salmonella Newport
Current outbreak: FDA has opened a new Salmonella Newport investigation, reference 1403. The food source has not yet been identified and traceback is underway.
Alfalfa sprouts: STEC + Salmonella
Current outbreak: FDA and CDC are investigating a multistate outbreak linked to recalled Calco and Everything Sprouts-brand alfalfa sprouts. The outbreak includes Shiga toxin-producing E. coli O26:H11, O103:H25, and O168:H8 plus Salmonella Agona. FDA's August 24 update reports 55 illnesses across 15 states, 4 hospitalizations, and no deaths. A product recall was initiated August 22. FDA also advises restaurants, retailers, and food-service operations to clean and sanitize surfaces and containers contacted by the recalled sprouts.
Listeria monocytogenes
Recent outbreak: FDA and CDC closed the multistate Clover Hill Dairy soft-cheese outbreak on August 26. The final investigation reported 15 illnesses across 4 states, 14 hospitalizations, and 1 death. Product and environmental samples from the dairy matched the outbreak strain, reinforcing the importance of environmental hygiene in food operations.
Candida auris
Current watch: C. auris continues to challenge healthcare and long-term-care environments because it can persist on surfaces and spread within facilities. CDC continues national clinical and screening surveillance.
Cyclospora
Current outbreak: FDA's August 20 update on the iceberg-lettuce Cyclospora outbreak lists 10,930 illnesses across 17 states, 454 hospitalizations, and 2 deaths. The investigation remains ongoing and is highly relevant to produce handling, food service, and cross-contamination control. FDA's CORE table also shows continued case growth in two additional Cyclospora investigations.
H5N1 Avian Influenza
Current outbreak: H5N1 remains an important animal-health and One Health concern for veterinary teams, shelters, farms, animal-care facilities, and workers handling potentially infected animals.
Measles
Current outbreak: CDC reports 2,777 confirmed U.S. measles cases in 2026 as of August 20. Measles is an enveloped virus, but airborne transmission control, vaccination, isolation, and public-health guidance remain central to response.
West Nile virus
Current outbreak: CDC's 2026 West Nile surveillance is active and current as of August 25. West Nile is primarily mosquito-borne, so vector control and public-health prevention remain the main response.
Mpox
Current outbreak: CDC continues mpox surveillance and published an August 20, 2026 MMWR review describing ongoing low-level U.S. transmission. EPA currently places mpox in Tier 1, the enveloped-virus category, under its Emerging Viral Pathogen pathway.
One Platform Across High-Risk Environments
EraDOCate gives different industries the same advantage: one product, broad EPA-labeled pathogen coverage, short contact times, controlled dilution, and one repeatable operating standard.
Representative label-listed priorities include MRSA, Pseudomonas aeruginosa, Acinetobacter baumanii, Influenza A, RSV, C. difficile, and C. auris. Contact time is organism-specific.
Representative hard-surface claims include Salmonella enterica, Salmonella Typhimurium, Listeria monocytogenes, E. coli O157:H7, Shigella dysenteriae, and Staphylococcus aureus. Food-contact sanitization has separate directions.
Representative label-listed organisms include Influenza A, RSV, Human Coronavirus 229E, Rhinovirus Type 37, Human Rotavirus, MRSA, and Norovirus surrogate claim.
Representative label-listed organisms include Avian Influenza A H9N2, Salmonella enterica, E. coli O157:H7, MRSA, Staphylococcus aureus, and Pseudomonas aeruginosa.
Many label-listed bacteria, viruses, fungi, and surrogates use the standard healthcare use solution at a 1-minute wet contact time.
C. difficile, C. auris, and Poliovirus Type 1 use the 4-minute wet contact time under the current primary EPA label.
Why Facilities Choose EraDOCate for Outbreak Readiness
EraDOCate combines speed, breadth, verification, and standardization in one platform, giving facilities a practical path to reduce product switching, duplicate inventory, and unnecessary protocol complexity while keeping high-priority pathogen coverage in the same operating system.
Many label-listed organisms use a 1-minute wet contact time, helping teams move through high-touch spaces, room turns, and shared environments efficiently.
EraDOCate brings bacteria, viruses, fungi, resistant healthcare organisms, foodborne pathogens, C. difficile, C. auris, and Poliovirus Type 1 into one EPA-registered disinfection platform with organism-specific contact times, reducing the need to build separate disinfectant routines around every threat.
Controlled dispensing, concentration verification, training, and documentation give facilities a stronger path from product purchase to consistent execution.
EPA registration, current label documents, EPA pathogen lists, and outbreak-source links are placed directly on this page for buyer verification.
The OCEAN Standard Makes EraDOCate Operational
EraDOCate goes beyond the chemistry. OCEAN turns one product into a repeatable facility standard built around the same five pillars used across the EraDOCate website: Oxidate, Clean Slate, EraDOCate System, Allow the Labeled Contact Time, and No Residue.
Use the EraDOCate chemistry platform according to the current EPA-accepted label and applicable facility procedures.
Establish a clean, measurable starting point before disinfection and verify the process where appropriate.
Connect controlled dilution, application, PPE, training, verification, documentation, and coaching into one operating standard.
Use the contact time required for the exact organism and labeled use. Many label-listed organisms use a 1-minute contact time, while specific organisms require longer contact times.
Support a residue-conscious finish where the current label and use directions apply, while keeping rinse and finish requirements tied to the exact labeled use.
Verify the Claims Before You Buy
EraDOCate puts the source documents in front of the buyer. Review the EPA label, EPA pathogen lists, current outbreak sources, and supporting evidence directly.
Bring EraDOCate Into Your Facility
Compare your current disinfectant program against EraDOCate on pathogen coverage, contact time, product count, storage, packaging, training, workflow, verification, and total operating fit. The goal is to see whether one standardized platform can replace unnecessary disinfectant complexity across your facility.
EraDOCator-60 EPA Reg. No. 54289-4-102813. Primary EPA Reg. No. 54289-4. EPA registration does not constitute EPA endorsement. Always read and follow the current label and SDS.
Priority organisms, current outbreaks, direct label claims, related strains, surrogate claims, EPA EVP status, product count, room-turn pressure, isolation areas, food-service workflow, animal-care biosecurity, dilution, contact time, staff training, storage, packaging, internal distribution, concentration verification, ATP where appropriate, and proof of execution.